<- Go Home

Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Market Cap

$697.6M

Volume

412.4K

Cash and Equivalents

$210.0M

EBITDA

$96.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$712.6M

Profit Margin

64.33%

52 Week High

$21.48

52 Week Low

$9.93

Dividend

5.00%

Price / Book Value

-0.91

Price / Earnings

12.12

Price / Tangible Book Value

-0.88

Enterprise Value

$2.1B

Enterprise Value / EBITDA

19.95

Operating Income

$59.2M

Return on Equity

7.45%

Return on Assets

3.13

Cash and Short Term Investments

$210.0M

Debt

$1.6B

Equity

-$768.8M

Revenue

$1.1B

Unlevered FCF

$33.0M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches